Synovial sarcoma of children and adolescents: The prognostic role of axial sites

被引:63
作者
Ferrari, Andrea [1 ]
Bisogno, Gianni [2 ]
Alaggio, Rita [3 ]
Cecchetto, Giovanni
Collini, Paola
Rosolen, Angelo [2 ]
Meazza, Cristina [1 ]
Indolfi, Paolo
Garaventa, Alberto [6 ]
De Sio, Luigi [7 ]
D'Angelo, Paolo [4 ,5 ,8 ]
Tamaro, Paolo [9 ]
Casanova, Michela [1 ]
Carli, Modesto [2 ]
机构
[1] IRCCS Fdn, Ist Nazl Tumori, Pediat Oncol Unit, I-20133 Milan, Italy
[2] Univ Padua, Div Pediat Haematol & Oncol, Padua, Italy
[3] Univ Padua, Dept Pathol, I-35100 Padua, Italy
[4] IRCCS Fdn, Ist Nazl Tumori, Dept Pathol, I-20133 Milan, Italy
[5] Univ Naples 2, Pediat Oncol Serv, Naples, Italy
[6] Giannina Gaslini Childrens Hosp, Dept Pediat Haematol Oncol, Genoa, Italy
[7] IRCCS, Osped Pediat Bambino Gesu, Div Pediat Oncol, Rome, Italy
[8] Osped Bambini G Di Cristina, Div Pediat Haematol & Oncol, Palermo, Italy
[9] Univ Trieste, I-34127 Trieste, Italy
关键词
axial sites; synovial sarcoma; childhood soft tissue sarcomas; prognostic factors; non-rhabdomyosarcoma soft tissue sarcomas;
D O I
10.1016/j.ejca.2008.03.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The outcome of patients with non-extremity synovial sarcoma (SS) is generally worse than that of patients with limb tumours. Methods: The present study analysed a series of 115 consecutive SS patients treated in Italian paediatric protocols (period 1979-2005), mainly focusing on the 30 cases arising from 'axial' sites (16 head-neck, 8 trunk, 4 lung-pleura and 2 retroperitoneum). Results: Initial gross resection was achieved in 40% of axial cases and in 80% of limb SS (p < 0.0001). Five-year EFS and overall survival (OS) were, respectively, 43.3% and 55.1% for axial SS, and 69.6% (p = 0.0068) and 84.0% (p = 0.0004) for extremity SS. Local progression/ recurrence was the cause of treatment failure in 75% of relapsing patients axial disease. Conclusions: Our findings emphasise that children and adolescents with SS originating at non-extremity locations have a worse prognosis than those with limb SS. Tumour site should be considered when defining a risk-adapted treatment strategy for SS. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1202 / 1209
页数:8
相关论文
共 46 条
[1]   Primary monophasic synovial sarcoma of the pleura - Five cases confirmed by the presence of SYT-SSX fusion transcript [J].
Aubry, MC ;
Bridge, JA ;
Wickert, R ;
Tazelaar, HD .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (06) :776-781
[2]  
Bégueret H, 2005, AM J SURG PATHOL, V29, P339
[3]   Synovial sarcoma of the upper digestive tract:: A report of two cases with demonstration of the X;18 translocation by fluorescence in situ hybridization [J].
Billings, SD ;
Meisner, LF ;
Cummings, OW ;
Tejada, E .
MODERN PATHOLOGY, 2000, 13 (01) :68-76
[4]   Grossly-resected synovial sarcoma treated by the German and Italian pediatric soft tissue sarcoma cooperative groups: Discussion on the role of adjuvant therapies [J].
Brecht, IB ;
Ferrari, A ;
Int-Veen, C ;
Schuck, A ;
Mattke, AC ;
Casanova, M ;
Bisogno, G ;
Carli, M ;
Koscielniak, E ;
Treuner, J .
PEDIATRIC BLOOD & CANCER, 2006, 46 (01) :11-17
[5]  
BRODSKY JT, 1992, CANCER-AM CANCER SOC, V70, P484, DOI 10.1002/1097-0142(19920715)70:2<484::AID-CNCR2820700217>3.0.CO
[6]  
2-7
[7]   Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma [J].
Eilber, Fritz C. ;
Brennan, Murray F. ;
Eilber, Frederick R. ;
Eckardt, Jeffery J. ;
Grobmyer, Stephen R. ;
Riedel, Elyn ;
Forscher, Charles ;
Maki, Robert G. ;
Singer, Samuel .
ANNALS OF SURGERY, 2007, 246 (01) :105-113
[8]   Primary pleuropulmonary synovial sarcoma - Reappraisal of a recently described anatomic subset [J].
Essary, LR ;
Vargas, SO ;
Fletcher, CDM .
CANCER, 2002, 94 (02) :459-469
[9]   Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution [J].
Ferrari, A ;
Gronchi, A ;
Casanova, M ;
Meazza, C ;
Gandola, L ;
Collini, P ;
Lozza, L ;
Bertulli, R ;
Olmi, P ;
Casali, PG .
CANCER, 2004, 101 (03) :627-634
[10]  
Ferrari A, 1999, MED PEDIATR ONCOL, V32, P32, DOI 10.1002/(SICI)1096-911X(199901)32:1<32::AID-MPO7>3.3.CO